Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Prothix B.V.
DescriptionAnti-inflammatory complement inhibitor
Molecular Target
Mechanism of ActionComplement inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationIschemia / reperfusion injury
Indication DetailsPrevent ischemia reperfusion damage
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today